期刊文献+

世界卫生组织基本药物遴选原则的进展研究 被引量:9

Development of Essential Medicines Selection Principles of WHO
原文传递
导出
摘要 目的:为我国基本药物的遴选和调整提供参考。方法:通过查阅世界卫生组织(WHO)系列技术报告,运用文献研究和比较研究方法进行分析。结果:WHO基本药物示范目录的遴选原则经多次补充完善,使得基本药物的遴选由经验决策转变为循证决策,剂型和规格更加规范,修订后的目录修订程序更加符合循证、公正和透明的原则。结论:我国应借鉴WHO的经验,完善符合我国国情的基本药物目录遴选和调整原则,完善基本药物制度体系。 OBJECTIVE: To put forward some suggestions for the selection and revision of essential medicines in China. METHODS: Reviewed WHO series technical reports, literatures study and comparison method was adopted. RESULTS: The selec- tion criteria for WHO Model List of Essential Medicines had been revised for several times, which made the selection of essential medicines change from experience-based decisions to evidence-based decision, dosage forms and specification were more standard, the new update and dissemination procedure was more consistent with the evidence-based, transparent and justice principle. CON- CLUSION: We should learn from WHO's experience, develop our own selection criteria of essential medicines and improve essen- tial medicine system in China.
出处 《中国药房》 CAS CSCD 北大核心 2011年第28期2593-2597,共5页 China Pharmacy
基金 中国/世界卫生组织2010-2011年度正规预算合作项目(WPCHN1004601)
关键词 基本药物 遴选 原则 进展 Essential medicines Selection Princople Development
  • 相关文献

参考文献19

  • 1Jeremy A Greene. When did medicines become essential [J]. Bull World Health Organ, 2010,88 : 483.
  • 2WHO. Revised procedure for updating WHO' s Model List of Essential Drugs[R]. EB 109/8 report, 2001 : 1.
  • 3WHO. WHO medicines strategy. Revised procedure for updating WttO' s Model List of Essential Drugs[R]. EB 109/8 report, 2001 : 3-4.
  • 4WHO. The selection and use of essential drugs, report of the WHO expert committee( WHO Technical Report Series 914) [R]. Geneva. World Health Organization, 2002.6, 8,14-16,25,40.
  • 5WHO. The use of essential drugs: second report of the WHO expert committee (WHO Technical Report Series 722) [R]. Geneva: World Health Organization, 1985: 9-11.
  • 6WHO. The use of essential drugs : third report of the WHO expert committee ( WHO Technical Report Series 770 ) [R]. Geneva : World Health Organization, 1988 : 11-12.
  • 7WHO. The use of essential drugs : fourth report of the WHO expert committee( WHO Technical Report Series 796) [R]. Geneva: World Health Organization, 1990 : 11-13.
  • 8WHO. The use of essential drugs : fifth report of the WHO expert committee ( WHO Technical Report Series 825 ) [R]. Geneva: World Health Organization, 1992 : 4-5.
  • 9WHO. The use of essential drugs: sixth report of the WHO expert committee (WHO Technical Report Series 850) [R]. Geneva: World Health Organization, 1995 : 4-6.
  • 10WHO. The use of essential drugs: seventh report of the WHO expert committee (WHO Technical Report Series 867)[R]. Geneva: World Health Organization, 1997 : 5-7.

二级参考文献23

  • 1张艳玲,胡风华,任小旭,张琪,王君,汪云,李莉.对乙酰氨基酚混悬剂和栓剂对发热患儿的疗效比较[J].实用儿科临床杂志,2005,20(9):867-868. 被引量:2
  • 2陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:604
  • 3张玉,马力,王佩佩.氟康唑口服液人体相对生物利用度和生物等效性[J].中国医院药学杂志,2007,27(4):470-472. 被引量:6
  • 4[1]WHO.Revised procedure for updating WHO's Model List of Essenial Drugs[G].EB109/8.Geneva:World Health Organization,2001.
  • 5[2]WHO.Access to Essential Medicines as a Global Necessity 25th Anniversary of the WHO Model List of Essential Medicines[EB/OL].[2006-05-20].http://www.who.int/dg/speeches/2002/ whoessentialmedicines/en/print.html.
  • 6[3]Laing R,Waning B,Gray A,et al.25 years of the WHO essential medicines lists:progress and challenges[J].The Lancet-Vol.361,Issue 9370,17 May 2003,Pages 1723-1729.
  • 7[4]WHO.WHO Policy Perspectives on Medicines-The Selection of Essential Medicines[G].Geneva:World Health Organization,2002.
  • 8[5]WHO.How to Develop and implement a national drug policy[G].Geneva:World Health Organization,2001.
  • 9[6]WHO.Technical Report Series WHO no 914[G].Geneva:World Health Organization,2003.
  • 10[7]WHO/EDM Department of Essential Drugs and Medicines Policy.Updating and disseminating the WHO Model List of Essential Drugs:the way forward[G].Geneva:World Health Organization,2001.

共引文献34

同被引文献96

  • 1孙静.WHO基本药物概念与国家实践[J].中国卫生政策研究,2009,2(1):38-42. 被引量:33
  • 2李立明.流行病学[M].北京:人民卫生出版社,2008:121-122.
  • 3新华网.解读国家基本药物制度[EB/OL].2009-08-21.http://www.xinhuanet.com/xhft/200908216/.
  • 4国家统计局.2010年第6次全国人口普查主要数据公报[EB/OL]. 2011-04-28. http ://www.stats.gov.cn/tjgb/rkpcgb/.
  • 5World Health Organization. WHO prequalification of medi eine programme update for 2006 [R]. Geneva: World Health Organization, 2007: 1-16.
  • 6World Health Organization. Procedure for prequalification of pharmaceutical products. Revision [ R]. Geneva: World Health Organization, 2011:374 -390.
  • 7World Health Organization. WHO prequalification of medi- cines for reproductive health [R]. Geneva: World Health Organization, 2012: 1-5.
  • 8World Health Organization. WHO list of prequalified medici- nal products [EB/OL]. [2012-11-05]. www. who. int/ prequal.
  • 9World Health Organization. Guidelines on submission of doc- umentation for a multisource (generic) finished product for the WHO prequalification of medicines programme: quality part [R]. Geneva: World Health Organization, 2012: 122-157.
  • 10World Health Organization. Guidelines on submission of doc- umentation for a multisource (generic) finished product: general format: preparation of product dossiers in common technical document format [R]. Geneva: World Health Or ganization, 2011:418 -427.

引证文献9

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部